Questcor Pharmaceuticals Earnings:Here’s Why the Stock is Falling Now
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 0%.
Questcor Pharmaceuticals, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 24.59% to $0.76 in the quarter versus EPS of $0.61 in the year-earlier quarter.
Revenue: Rose 40.8% to $135.13 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Questcor Pharmaceuticals, Inc. reported adjusted EPS income of $0.76 per share. By that measure, the company missed the mean analyst estimate of $0.96. It missed the average revenue estimate of $157.16 million.
Quoting Management: “Our first quarter results were below our expectations,” said Don M. Bailey, President and CEO of Questcor. “However, vial shipment activity and prescription levels in MS and rheumatology in late March and throughout April appear to indicate that positive sales momentum has returned. In particular, we note that our newest initiative related to the promotion of Acthar for dematomyositis and polymyositis is off to a strong start.”
Key Stats (on next page)…
Revenue decreased 15.82% from $160.53 million in the previous quarter. EPS decreased 30.28% from $1.09 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.97 to a profit $1.05. For the current year, the average estimate has moved up from a profit of $3.94 to a profit of $4.16 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.